The North American synthetic biology market is anticipated to grow at a CAGR of 31.0% during the forecast period. The market growth is attributed to the increasing demand for bio-based products, rising R&D funding for synthetic biology, and increased investments by synthetic biology companies. Further, the growing support from the government, private institutions, and increasing R&D investments in the development of the drugs are other major factors that are expected to drive the North American synthetic biology market growth during the forecast period.
To Request a Sample of our Report on North American Synthetic Biology Market: https://www.omrglobal.com/request-sample/north-american-synthetic-biology-market
Furthermore, technological advancements in the life science sector have resulted in increased speed and reduced cost of DNA amalgamation. This enables researchers to design and integrate adjusted bacterial chromosomes that can be utilized as a part of the generation of cutting-edge biofuels, bio-items, sustainable chemicals, and others. The advancements in modern engineering have enabled scientists to build new sequences of DNA.
The North American synthetic biology market is segmented on the basis of product, technology, and applications. Based on the product, the market is segmented into enabling products, core products, and enabled products. Core product includes synthetic genes, synthetic cells, synthetic DNA, chassis organisms and Xeno Nucleic Acid (XNA), and are expected to hold a significant share in the market owing to extensive use of core products in R&D. Based on technology, the market is segmented into, and gene synthesis & sequencing, genome engineering, bioinformatics, and others. Based on application, the market is segmented into medical applications, industrial applications, food & agriculture, and environmental applications.
(Get 15% Discount on Buying this Report)
A full Report of Peptide and Anticoagulant Drug Market is Available @ https://www.omrglobal.com/industry-reports/north-american-synthetic-biology-market
Synthetic Biology Market Segmentation
By Product
- Enabling Product
- Core Product
- Enabled Product
By Technology
- Gene Synthesis & Sequencing
- Genome Engineering
- Bioinformatics
- Others
By Application
- Medical Application
- Industrial Application
- Food & Agriculture
- Environmental Application
Regional Analysis
- US
- Canada
Company Profiles
- Algenol
- Amyris, Inc.
- Butamax Advanced Biofuels LLC
- Codexis, Inc.
- DNA TwoPointO, Inc. (ATUM)
- E. I. du Pont de Nemours and Co.
- Editas Medicine, Inc.
- Genewiz, Inc.
- GenScript Biotech Corp.
- Intellia Therapeutics, Inc.
- Integrated DNA Technologies, Inc.
- Merck KGaA
- OriGene Technologies, Inc.
- Synthetic Genomics, Inc.
- Synthorx, Inc.
- Thermo Fisher Scientific, Inc.
- Twist Bioscience Corp.
- Vedanta Biosciences, Inc.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
